Explore Insights

Find what matters to you

Blog
When Early Decisions Shape Late-Stage Risk

Early clinical decisions shape regulatory risk and the path to approval   Assumptions about study design and real-world execution don’t stay contained to a single milestone. Over time, they influence […]

Read More
Blog
The Cohesion Museum Convergence

Four scientific principles. One unifying concept. The Cohesion Effect experience. SCOPE Summit is a place where innovation thrives. Thousands of attendees and hundreds of exhibitors from around the world, all […]

Read More
Blog
The Sponsor and CRO Symbiosis Effect: How cohesion carried us through a high-pressure NDA

When Tonix came to us, the stakes were high, and the timelines were tight. Their goal? To submit a New Drug Application (NDA) for TONMYA™ and, for the first time […]

Read More
Blog
The CRO Decoder: What Site-Centric Really Means (And What it Doesn’t)

Every CRO out there will tell you they’re site-centric, and on pitch decks, they use the right buzzwords to prove it.  Curious. Collaborative. Dependable. Problem-solvers. Sound familiar?   That’s great in […]

Read More
Blog
The Lean Team Playbook: How small biotechs can nail ICH E6(R3) without a large QA team

You’re responsible for showing risk oversight, protocol clarity, and a site-friendly design—but you’ve got a lean team, a looming trial, and no time to decode the 110-page ICH E6(R3) guidance. […]

Read More
Guides
The R3 Timewarp Redemption: Preventable risks and how to avoid them in a trial

Picture this: a complex trial is running, but it has been plagued with issues from the start. From multiple delays to cost overruns, and now with quality concerns creeping in—it […]

Read More
Blog
The MythBusters Revelations: Debunking compliance myths to keep your trial on track

ICH E6(R3) is here, and with it, clinical teams are bracing for the impacts. Biotechs are being asked to develop clear and concise protocols, demonstrate oversight throughout the trial, integrate […]

Read More
Case Study
The Site Cohesion Hypothesis: 3 examples of the impact of CRO site relationships

Behind every enrollment milestone is a web of relationships—some strong, some strained, and some that make all the difference. At Rho, we don’t just talk about site engagement. We live […]

Read More
Guides
The Site Stickiness Hypothesis: Good site relationships pay dividends

Every CRO claims to value sites. But the true nature of their site relationships could determine the outcome of your trials. You deserve a partner that builds site relationships the […]

Read More
Blog
Reform of the European Union Pharmaceutical Legislation (Adoption Stage TBD)

On 26 April 2023, the European Commission (EC) proposed reforming the European Union (EU) pharmaceutical legislation. This revision constitutes the first major overhaul of the pharmaceutical legislation since 2004. It will adapt the legislation to the needs of the 21st century.

Read More
Scroll to Top